Product Information

RITALIN 5 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $0.7953 per EA under NDC 00078043905. Its NADAC has been published 411 times since Nov 28, 2013.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RITALIN 5 MG TABLET

methylphenidate hydrochloride
$0.7953per EA
DEA Schedule CII

Strength

5 mg/1

NDC

00078043905

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

7/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA010187

FDA Approved

Before 1982

TE Code

AB

On Market Since

12/31/1955

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for RITALIN 5 MG TABLET has been published 411 times since Nov 28, 2013, and over the history we have for it it has risen 23.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7953 per EA
All-time high$0.8047 (Apr 15, 2026)
All-time low$0.6284 (Dec 23, 2020)
52-week high$0.8047
52-week low$0.7953
Median price$0.6447
Average price$0.6932
Largest weekly change+15.6% (Jul 19, 2023)
Weeks tracked411
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

0.0%

3M

-0.5%

6M

-0.1%

1Y

-0.2%

3Y

+9.4%

5Y

+26.6%

All

+23.5%

Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of RITALIN 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RITALIN 5 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $0.7953 per EA (NDC 00078043905), effective Jul 29, 2026.

How has the price of RITALIN 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for RITALIN 5 MG TABLET has risen 23.5%. It has been tracked across 411 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RITALIN 5 MG TABLET?

Since Nov 28, 2013, the NADAC for RITALIN 5 MG TABLET has ranged from a low of $0.6284 (Dec 23, 2020) to a high of $0.8047 (Apr 15, 2026), with a median of $0.6447 per EA.

Are there cheaper alternatives to RITALIN 5 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RITALIN 5 MG TABLET, is $0.7926 per EA — about 0% below RITALIN 5 MG TABLET.

Who manufactures RITALIN 5 MG TABLET?

RITALIN 5 MG TABLET (NDC 00078043905) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.